Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall alert for ketamine anaesthetic
A batch of Anesketin 100 mg/ml solution for injection has been recalled owing to vial closure integrity.

Dechra Ltd initiates Class 1 recall for a single batch of Anesketin solution for injection.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Anesketin 100 mg/ml solution for injection manufactured by Dechra Ltd.

In a news release, the VMD writes: 'We wish to make wholesalers and veterinary surgeons aware that Dechra Ltd has initiated a Class I recall to veterinary level with immediate effect for batch 140461 of Anesketin 100 mg/ml solution for injection for dogs, cats and horses.

'The reason for the recall is a compromised closure of the vials. Dechra Ltd is contacting wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.'

Further information about the recall is available from Dechra's UK Customer Services Team on 01939 211200.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.